Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023
Cash flows from operating activities:
Net income	$ 504,528	$ 407,006
Adjustments to reconcile net income to net cash provided by operating activities:
Loss (gain) from disposal of assets, impairments and other	(1,603)	12,558
Depreciation	463,920	417,380
Amortization of intangibles	84,414	78,335
Deferred income taxes, net of acquisitions	47,592	31,427
Current period provision for expected credit losses	8,756	7,035
Amortization of debt issuance costs	5,960	3,241
Share-based compensation	40,813	41,469
Interest accretion	19,227	9,835
Adjustments to contingent consideration	(500)	(910)
Other	1,694	(2,828)
Changes in operating assets and liabilities, net of effects from acquisitions:
Net change in operating assets and liabilities, net of acquisitions	(73,114)	12,164
Net cash provided by operating activities	1,101,687	1,016,712
Cash flows from investing activities:
Payments for acquisitions, net of cash acquired	(1,435,704)	(213,152)
Capital expenditures for property and equipment	(387,170)	(394,143)
Proceeds from disposal of assets	2,997	3,819
Proceeds from sale of investment in noncontrolling interests	37,000	0
Other	(11,227)	(1,145)
Net cash used in investing activities	(1,794,104)	(604,621)
Cash flows from financing activities:
Proceeds from long-term debt	3,140,648	538,421
Principal payments on notes payable and long-term debt	(2,234,998)	(768,059)
Payment of contingent consideration recorded at acquisition date	(12,496)	(2,193)
Change in book overdraft	1,350	(234)
Payments for cash dividends	(147,271)	(131,140)
Tax withholdings related to net share settlements of equity-based compensation	(31,264)	(28,675)
Debt issuance costs	(12,557)	0
Proceeds from issuance of shares under employee share purchase plan	2,183	1,841
Proceeds from sale of common shares held in trust	286	765
Other	(4,000)	0
Net cash provided by (used in) financing activities	701,881	(389,274)
Effect of exchange rate changes on cash, cash equivalents and restricted cash	(1,096)	154
Net increase in cash, cash equivalents and restricted cash	8,368	22,971
Cash, cash equivalents and restricted cash at beginning of period	184,038	181,364
Cash, cash equivalents and restricted cash at end of period	192,406	204,335
In connection with its acquisitions, the Company assumed liabilities as follows:
Payments for acquisitions, net of cash acquired	(1,435,704)	(213,152)
Liabilities assumed and notes payable issued to sellers of businesses acquired	$ 157,293	$ 45,669